{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:16:34Z","timestamp":1794111394528,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL117904"],"award-info":[{"award-number":["U01HL117904"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL117905"],"award-info":[{"award-number":["U01HL117905"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ahj.2018.07.023","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T22:20:01Z","timestamp":1533075601000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["International Study of Comparative Health Effectiveness with Medical and Invasive Approaches\u2013Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design"],"prefix":"10.1016","volume":"205","author":[{"given":"Sripal","family":"Bangalore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome L.","family":"Fleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen P.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S.","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ahj.2018.07.023_bb0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ahj.2018.07.023_bb0010","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.ahj.2018.07.023_bb0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.023_bb0020","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.CIR.93.5.905","article-title":"Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification","volume":"93","author":"Hachamovitch","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.07.023_bb0025","series-title":"2016 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases","author":"United States Renal Data System","year":"2016"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.023_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ahj.2018.07.023_bb0035","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.ahj.2018.07.023_bb0040","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.117.027338","article-title":"Cardiovascular outcome trials in patients with advanced kidney disease: time for action","volume":"135","author":"Zannad","year":"2017","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ahj.2018.07.023_bb0045","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Group BDS","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ahj.2018.07.023_bb0050","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.amjcard.2009.07.043","article-title":"Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease","volume":"104","author":"Sedlis","year":"2009","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2018.07.023_bb0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ahj.2018.07.023_bb0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2018.07.023_bb0065","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2018.07.023_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001380","article-title":"Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry","volume":"3","author":"Tsai","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.ahj.2018.07.023_bb0075","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.amjmed.2016.06.046","article-title":"Optimal treatment strategies in patients with chronic kidney disease and coronary artery disease","volume":"129","author":"Volodarskiy","year":"2016","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ahj.2018.07.023_bb0080","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/01.ASN.0000083900.92829.F5","article-title":"Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease","volume":"14","author":"Reddan","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.023_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.023_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9149(03)00716-1","article-title":"Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes","volume":"92","author":"Keeley","year":"2003","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.ahj.2018.07.023_bb0095","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ahj.2018.07.023_bb0100","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.023_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0735-1097(02)02848-6","volume":"41","author":"Gibbons","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ahj.2018.07.023_bb0110","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 3","key":"10.1016\/j.ahj.2018.07.023_bb0115","first-page":"S1","article-title":"KDOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"National Kidney Foundation","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2018.07.023_bb0120","doi-asserted-by":"crossref","first-page":"c125","DOI":"10.1159\/000328065","article-title":"Renal association clinical practice guideline on cardiovascular disease in CKD","volume":"118","author":"Holt","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ahj.2018.07.023_bb0125","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2013","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ahj.2018.07.023_bb0130","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.023_bb0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ahj.2018.07.023_bb0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"issue":"9784","key":"10.1016\/j.ahj.2018.07.023_bb0145","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.023_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.023_bb0155","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/01.WNL.0000161845.69114.62","article-title":"Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging","volume":"64","author":"Josephson","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ahj.2018.07.023_bb0160","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","article-title":"\"Renalism\": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency","volume":"15","author":"Chertow","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.023_bb0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCULATIONAHA.110.970160","article-title":"Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography","volume":"123","author":"James","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.023_bb0170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study","volume":"47","author":"Rudnick","year":"1995","journal-title":"Kidney Int"},{"issue":"9931","key":"10.1016\/j.ahj.2018.07.023_bb0175","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ahj.2018.07.023_bb0180","first-page":"1076","article-title":"A novel technique for ultra-low contrast administration during angiography or intervention","volume":"75","author":"Nayak","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"40","key":"10.1016\/j.ahj.2018.07.023_bb0185","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1093\/eurheartj\/ehw078","article-title":"Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study","volume":"37","author":"Ali","year":"2016","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ahj.2018.07.023_bb0190","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.023_bb0195","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2018.07.023_bb0200","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.07.023_bb0205","first-page":"10(4)","author":"Lonborg","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"8826","key":"10.1016\/j.ahj.2018.07.023_bb0210","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0140-6736(92)93010-K","article-title":"Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure","volume":"340","author":"Manske","year":"1992","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.023_bb0215","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle angina questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.ahj.2018.07.023_bb0220","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/CIRCOUTCOMES.113.000752","article-title":"Comparison of the Seattle Angina Questionnaire with daily angina diary in the TERISA clinical trial","volume":"7","author":"Arnold","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"10.1016\/j.ahj.2018.07.023_bb0225","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0002-9149(94)90555-X","article-title":"Monitoring the quality of life in patients with coronary artery disease","volume":"74","author":"Spertus","year":"1994","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.023_bb0230","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.ahj.2018.07.023_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.ahj.2018.07.023_bb0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2018.04.011","article-title":"International study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) trial: rationale and design","volume":"201","author":"Group ITR","year":"2018","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.023_bb0245","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004791","article-title":"ISCHEMIA: establishing the primary end point","volume":"11","author":"Bangalore","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:56:47Z","timestamp":1762077407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"alternative-id":["S0002870318302357"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.07.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Study of Comparative Health Effectiveness with Medical and Invasive Approaches\u2013Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}